臨床診断薬市場：検査、製品、エンドユーザー別-2025-2030年の世界予測

臨床診断薬市場は、2023年に778億米ドルと評価され、2024年には841億7,000万米ドルに達すると予測され、CAGR 8.59％で成長し、2030年には1,385億3,000万米ドルに達すると予測されています。

臨床診断薬市場は、疾病の検出、モニタリング、管理のための検査やツールの応用と開拓を中心に、幅広い範囲を網羅しています。慢性疾患の増加、高齢化、個別化医療への需要の高まりにより、重要なヘルスケア分野となっています。臨床診断薬は、病院から検査室まで様々な医療現場で応用され、がん検出、感染症検査、心血管健康、遺伝子検査などの最終用途に利用されています。成長要因としては、分子診断の進歩、ポイントオブケア検査の登場、検査速度と精度を高めるためのAIと機械学習技術の統合などが挙げられます。新興国市場への診断薬の普及、在宅検査ソリューションの強化、複数の検査を統合して利便性と費用対効果を提供できるマルチプレックス診断プラットフォームの開発などに市場開拓の機会があります。しかし、規制上のハードル、高度な診断システムの高コスト、データ・プライバシーの問題などの課題が、市場成長の制約となっています。コスト削減、自動化の進展、アクセシビリティの向上をターゲットとした技術革新は、市場の可能性を大幅に高める可能性があります。さらに、資源不足の地域向けに迅速で使いやすい診断ツールの開発に注力することで、未開拓市場の成長に拍車をかけることができます。テクノロジー企業とヘルスケアプロバイダーとのパートナーシップを構築することで、迅速で信頼性の高い診断に対する消費者の要求に応えるソリューションを加速することができます。ゲノミクスやプロテオミクスのような分野における継続的な研究により、新製品開発が促進され、個別化ヘルスケアに関する知見が得られると期待されます。市場の性質は依然としてダイナミックであり、デジタルソリューションと従来の診断法を統合する傾向があり、堅牢なデータ分析能力の重要性が強調されています。これらの側面に対処し、規制状況の変化を把握しながら、拡張性と適応性の高い技術に投資することが、進化する臨床診断薬の状況を活用しようとする企業にとって鍵となります。

市場力学：急速に進化する臨床診断薬市場の主要市場インサイトを公開

臨床診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症および慢性疾患の罹患率の上昇
  • 自動診断プラットフォームの採用
  • 遺伝子検査ニーズの高まり
• 市場抑制要因
  • セットアップと機器のコストが高い
• 市場機会
  • 臨床診断薬機器の新開発
  • 臨床研究への投資の増加
• 市場の課題
  • 熟練した臨床検査技師の不足

ポーターの5つの力：臨床診断薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臨床診断薬市場における外部からの影響の把握

外部マクロ環境要因は、臨床診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臨床診断薬市場における競合情勢の把握

臨床診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臨床診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臨床診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臨床診断薬市場における成功への道筋を描く

臨床診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症および慢性疾患の発生率の上昇
    • 自動診断プラットフォームの導入
    • 遺伝子検査の必要性が高まる
  • 抑制要因
    • セットアップと機器のコストが高い
  • 機会
    • 臨床診断薬機器の新開発
    • 臨床調査への投資の増加
  • 課題
    • 熟練した研究員が限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臨床診断薬市場テスト別

• 電解質検査の臨床診断薬
• 感染症検査の臨床診断薬
• 完全血球計算臨床診断薬
• 脂質パネル臨床診断薬
• 肝臓パネル臨床診断薬
• 腎臓パネル臨床診断薬

第7章 臨床診断薬市場：製品別

• 機器
• 試薬

第8章 臨床診断薬市場：エンドユーザー別

• 診断検査室
• 病院の検査室
• ポイントオブケア検査

第9章 南北アメリカの臨床診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の臨床診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの臨床診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Bioscientia Healthcare GmbH
• Charles River Laboratories International, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Hologic Inc.
• Ortho-Clinical Diagnostics, Inc.
• Quest Diagnostics Inc.
• Siemens AG
• Sonic Healthcare Limited
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL DIAGNOSTICS FOR ELECTROLYTE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL DIAGNOSTICS FOR INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIVER PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY RENAL PANEL CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 49. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CHINA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 52. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 104. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. ITALY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 116. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. POLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 119. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. QATAR CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM CLINICAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Clinical Diagnostics Market was valued at USD 77.80 billion in 2023, expected to reach USD 84.17 billion in 2024, and is projected to grow at a CAGR of 8.59%, to USD 138.53 billion by 2030.

The clinical diagnostics market encompasses a wide scope, focusing on the application and development of tests and tools for disease detection, monitoring, and management. It is a crucial healthcare segment owing to the rising prevalence of chronic diseases, aging populations, and the increasing demand for personalized medicine. Clinical diagnostics are applied in various medical settings, from hospitals to laboratories, and utilized for end-use in cancer detection, infectious disease testing, cardiovascular health, and genetic testing, among others. Influencing growth factors include advancements in molecular diagnostics, the advent of point-of-care testing, and the integration of AI and machine learning technologies to increase test speed and accuracy. Opportunities lie in expanding the reach of diagnostics into emerging markets, enhancing home testing solutions, and developing multiplex diagnostic platforms that can consolidate multiple tests, offering convenience and cost-effectiveness. However, challenges such as regulatory hurdles, high costs of advanced diagnostic systems, and data privacy issues pose limitations on market growth. Innovations targeting cost reduction, increased automation, and improved accessibility can significantly enhance market potential. Furthermore, focusing on developing rapid and easy-to-use diagnostic tools for under-resourced areas can spur growth in untapped markets. Structuring partnerships between technology firms and healthcare providers can accelerate solutions that meet consumer demands for quick and reliable diagnostics. Continuous research in areas like genomics and proteomics is expected to drive new product development and provide personalized healthcare insights. The nature of the market remains dynamic, with a trend towards integrating digital solutions with traditional diagnostics, emphasizing the importance of robust data analytics capabilities. Addressing these aspects and maintaining a pulse on regulatory changes, while investing in scalable and adaptive technologies, will be key for businesses seeking to leverage the evolving landscape of clinical diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Diagnostics Market

The Clinical Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of infectious and chronic diseases
  • Adoption of automated diagnostic platforms
  • Increasing need for genetic test
• Market Restraints
  • High setup and instruments cost
• Market Opportunities
  • New developments in clinical diagnostics equipments
  • Increasing investment for clinical research
• Market Challenges
  • Limited skilled laboratory persons

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Diagnostics Market

A detailed market share analysis in the Clinical Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Diagnostics Market

A strategic analysis of the Clinical Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, Bioscientia Healthcare GmbH, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Ortho-Clinical Diagnostics, Inc., Quest Diagnostics Inc., Siemens AG, Sonic Healthcare Limited, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test, market is studied across Clinical Diagnostics for Electrolyte Testing, Clinical Diagnostics for Infectious Disease Testing, Complete Blood Count Clinical Diagnostics, Lipid Panel Clinical Diagnostics, Liver Panel Clinical Diagnostics, and Renal Panel Clinical Diagnostics.
• Based on Product, market is studied across Instruments and Reagents.
• Based on End-User, market is studied across Diagnostic Laboratories, Hospital Laboratories, and Point-of-Care Testing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of infectious and chronic diseases
    • 5.1.1.2. Adoption of automated diagnostic platforms
    • 5.1.1.3. Increasing need for genetic test
  • 5.1.2. Restraints
    • 5.1.2.1. High setup and instruments cost
  • 5.1.3. Opportunities
    • 5.1.3.1. New developments in clinical diagnostics equipments
    • 5.1.3.2. Increasing investment for clinical research
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled laboratory persons
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Diagnostics Market, by Test

• 6.1. Introduction
• 6.2. Clinical Diagnostics for Electrolyte Testing
• 6.3. Clinical Diagnostics for Infectious Disease Testing
• 6.4. Complete Blood Count Clinical Diagnostics
• 6.5. Lipid Panel Clinical Diagnostics
• 6.6. Liver Panel Clinical Diagnostics
• 6.7. Renal Panel Clinical Diagnostics

7. Clinical Diagnostics Market, by Product

• 7.1. Introduction
• 7.2. Instruments
• 7.3. Reagents

8. Clinical Diagnostics Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Hospital Laboratories
• 8.4. Point-of-Care Testing

9. Americas Clinical Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Clinical Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories Inc.
• 4. bioMerieux SA
• 5. Bioscientia Healthcare GmbH
• 6. Charles River Laboratories International, Inc.
• 7. Danaher Corporation
• 8. F. Hoffmann-La Roche AG
• 9. Hologic Inc.
• 10. Ortho-Clinical Diagnostics, Inc.
• 11. Quest Diagnostics Inc.
• 12. Siemens AG
• 13. Sonic Healthcare Limited
• 14. Sysmex Corporation
• 15. Thermo Fisher Scientific, Inc.